| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 90494-31-8 | Tylonolide,23-amino-23-deoxy-5-O-[3,6-dideoxy-3-(dimethylamino)-b-D-glucopyranosyl]- (9CI); Oxacyclohexadecane,tylonolide deriv. |  | C31H52N2O9 | 详情 | 供应商 | |
| 98603-84-0 | 唾液酸化酶X | SIALYL LEWIS X; 5-ACETAMIDO-3,5-DI-DEOXY-D-GLYCERO-ALPHA-D-GALACTO-2-NOULOPYRANOSYL(2-3)-BETA-D-GALACTOPYRANOSYL(1-4)-[ALPHA-L-FUCOPYRANOSYL(1-4)]-2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSIDE; 3'-SIALYL LEWIS; 3'-SIALYL-LEWISX; 3'-SIALYL-LEWIS-X TETRASACCHARIDE; NEU5AC-ALPHA2,3GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC; NEU5AC-ALPHA2,3GALBETA1,4(FUCALPHA1,3)GLCNAC, SODIUM SALT; NEUNAC-ALPHA2-3GAL-BETA1-4(FUC-ALPHA1-3)GLCNAC; NEU5AC2-A-3GAL1-B-4[FUC1-A-3]GLCNAC |  | C31H52N2O23 | 详情 | 供应商 |
| 92448-22-1 | SIALYL LEWIS A, SODIUM SALT; 3'-SIALYL-LEWIS-A TETRASACCHARIDE; ALPHA-NEU-5AC-[2->3]-BETA-D-GAL-[1->3]-[ALPHA-FUC-(1->4)]-D-GLCNAC; SIALYL LEWIS A, SODIUM SALT; NEU5AC2-A-3GAL1-B-3[FUC1-A-4]GLCNAC; α-neunac-(2→3)-β-d-gal-(1→3)-(α-l-fuc-[1→4])-d-glcnac; (2S,4S,5R,6R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4R,5R)-2-acetamido-5,6-dihydroxy-1-oxo-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid; 3''-SIALYL LEWIS A [NEUNAC-ALPHA2-GAL-SS1-3(FUC-ALPHA1-4)GLCNAC]; Neu5Ac2-α-3Gal1-β-3[Fuc1-α-4]GlcNAc |  | C31H52N2O23 | 详情 | 供应商 |
sitemap.xml